INTRODUCTION
G-proteins involved in transmembrane signalling are heterotrimers composed of a, / and y subunits, with molecular masses of 40-45, 35-36 and 5-8 kDa respectively. The a subunits bind and hydrolyse GTP; they are substrates for ADP-ribosylation by bacterial toxins, and they carry the specificity for receptors and effectors (Birnbaumer et al., 1990) .
There are several structural and functional differences between a subunits. The mammalian genome codes for several types of a subunits, including four a,, three a,, one a,, one at and one ax1f (for review, see Birnbaumer et al., 1990) . Some of these subunits have well-defined functions: a. couples stimulatory receptors to adenylate cyclase (Gilman, 1984) and Ca2+ channels (Yatani et al., 1987) , ai may be involved in the inhibition of adenylate cyclase (Jakobs et al., 1976) and in the opening of K+ channels (Kurachi et al., 1986) , ac acts in the closing of Ca2+ channels (Holz et al., 1986) , and a, couples photolysed rhodopsin with the stimulation of cyclic GMP phosphodiesterase activity (Stryer, 1986) .
Previous evidence from our laboratory indicates that Trypanosoma cruzi membranes have a 45 kDa polypeptide that can be ADP-ribosylated by cholera toxin. In addition, after electrofusion of T. cruzi and lymphoma S49 cyc-cells, a heterologous adenylate cyclase is reconstituted that is then activated by isoprenaline or fluoride . This strongly suggests the existence in T. cruzi membranes of an as polypeptide.
The present paper reports evidence for the existence in T. cruzi membranes ofa 43 kDa polypeptide that shows several functional and immunological properties that are characteristic of Ga. subunits. In addition, results presented here indicate the presence in these membranes of a 30 kDa polypeptide immunoreacting with an antiserum to G,8-subunit.
MATERIALS AND METHODS Materials
The sources of materials used in this work are given elsewhere Muschietti et al., 1989) .
Antisera raised against synthetic peptides that correspond to defined regions of G-protein subunits (Mumby et al., 1986; Goldsmith et al., 1988; Simonds et al., 1989) (KENLKDCGLF) was obtained from Biodynamics (Martinez, Argentina).
Membrane preparation
Liver plasma membranes were prepared by the procedure of Neville (1968) . T. cruzi membranes were prepared as described by Torruella et al. (1986) .
Detergent extraction of T. cruzi membranes
Membranes were suspended (10 mg of protein/ml) in 50 mMTris/HCl buffer, pH 7.5, containing 1 mM-/J-mercaptoethanol and 1 % (w/v) sodium cholate, left in ice for 2 h with magnetic stirring, and centrifuged for 60 min at 105000 g. The detergent concentration in the extract was lowered by filtration through Ultrogel AcA34. The column (1.4 cm x 40 cm), equilibrated with 50 mM-Tris/HCl buffer, pH 7.5, containing 0.1 % sodium cholate, was loaded with 1.5 ml of the supernatant (9 mg of protein). Elution (0.5 ml/min) was performed at 4°C; 1.5 ml fractions were collected. Fractions with the highest GTP[S]-binding activity were pooled and stored at 4°C (giving the 'Ultrogel fraction').
GTP-binding assay
Binding of GTP[35S] to purified protein fractions was carried * To whom correspondence should be addressed.
Vol . out by the procedure of Northup et al. (1982) with the modifications indicated by Waldo et al. (1987) . Under the conditions for the assay procedure, GTP binding was proportional to the protein concentration.
NADI and pertussis-toxin treatment of membrane proteins Very fresh T. cruzi membranes or bovine rod-outer-segment membranes (0.1 mg of protein/assay) were incubated for 30 mn at 30°C in 50 mM-Tris/HCl buffer, pH 7.4, containing 2 mmMgCl2, 1 mM-EDTA, 10 mm-dithiothreitol, 0.01 % (v/v) Lubrol, 1 mM-ATP, 0.2 mM-GTP, 1 lzM-[adenylate-32P]NAD+ (sp. radioactivity 40000 c.p.m./pmol) and 12 ,ug of activated pertussis toxin (preincubated at a concentration of 0.4 mg/ml, in the presence of 10 mM-dithiothreitol). Total volume was 0.06 ml. After incubation, a 0.025 ml sample was diluted in 0.5 ml of 3 % (w/v) SDS and precipitated by addition of 0.5 ml of cold 30 % (w/v) trichloroacetic acid. The precipitate was collected on nitrocellulose filters, washed five times with 6 % trichloroacetic acid and counted for radioactivity. The rest of the incubation mixture was adjusted to final concentrations of ATP and NAD+ of 10 mm and 5 mm respectively and then subjected to SDS/PAGE. The resolved polypeptides were transferred from the gel to a nitrocellulose membrane, which was further exposed to a radioautographic film.
In (Kornblihtt et al., 1981) . Polypeptide transfer from polyacrylamide gels to nitrocellulose membranes was carried out by electrotransference (KhyseAndersen, 1984) . For reaction with antibodies, the membranes after the transfer were blocked with a suspension of non-fat milk (Johnson et al., 1984) . After reaction with the corresponding antibody, detection was carried out with the Vectastain ABC-AP kit (Vector Laboratories, Burlingame, CA, U.S.A.), by following the instructions of the manufacturer. Controls were performed either with pre-immune rabbit serum or with 200 ItM specific peptide. In this latter case conditions were those described by Burstein & Macara (1989 binding activity co-eluted with a factor which, in a heterologous reconstitution system, blocked glucagon stimulation of adenylate cyclase activity in liver membranes (Fig. la) . This capacity to block hormone stimulation of liver adenylate cyclase might be the consequence of a putative G,-protein extracted from T. cruzi membranes. As shown in Fig. 1(b) , in crude extracts, membranes and the binding-activity peak fractions a 43 kDa polypeptide band was identified that immunoreacted with the AS/7 anti-ai antibody. This band was not observed in column fractions devoid of GTP[S]-binding activity.
ADP-ribosylation of Gai polypeptides by pertussis toxin decreases their ability to block adenylate cyclase activation (Gilman, 1984) . For this reason, the blocking capacity of cholate extracts from T. cruzi membranes treated with pertussis toxin and NADI was also examined. Under the selected conditions, the putative polypeptide acceptor seemed to be fully ADPribosylated. As shown in Fig. 2 , extracts from untreated membranes, but not from toxin-treated membranes, blocked glucagon stimulation of adenylate cyclase activity in liver membranes. This strongly suggests the involvement of a T. cruzi Gai protein in this effect.
ADP-ribosylation with pertussis toxin ADP-ribosylation catalysed by Bordetella pertussis toxin has been used for specific identification of Ga1, Gat and Gao subunits in crude membranes (Gilman, 1984) . Consequently, T. cruzi membranes were incubated with activated pertussis toxin plus [adenylate-32P]NAD', and the incorporation of radioactivity into a trichloroacetic acid-insoluble product was determined. As shown in Fig. 3 , after resolution of membrane polypeptides by SDS/PAGE a labelled product was detected with an electrophoretic mobility slightly slower than that of ADP-ribosylated transducin. The apparent molecular mass of this product was approx. 43 kDa.
On the other hand, the incorporation was dependent on the presence of this toxin and could be displaced by addition of unlabelled NADI (results not shown).
Characterization with specific antisera
Further characterization of the putative T. cruzi G, protein was performed by analysis ofmembrane polypeptides by Western blotting and further reaction with antisera raised against synthetic peptides corresponding to conserved sequences of G-protein subunits. Reaction with GA/I (anti-acommon) or with AS/7 (antiat, anti-a,l and anti-a12) polyclonal antibodies led to the identification of specific polypeptide bands with mobilities corresponding to about 43 kDa (Figs. 4a, 4b and 4c) . In contrast, the RM/I antibody (anti-a.) revealed a polypeptide band of about 46 kDa (Fig. 4d) , which is similar to that previously reported by this laboratory for the cholera-toxin ADPribosylated polypeptide .
On the other hand, the reaction of membrane polypeptides with the SW/I (anti-,f) antibody revealed a specific polypeptide band with a mobility corresponding to about 30 kDa (Fig. 4e) . The size of this G,-like polypeptide is smaller than those of the two types of fi subunits identified in higher eukaryotic organisms, with molecular masses of approx. 35-36 kDa (Birnbaumer et al., 1990 
